There is underreporting of adverse effects from vaccines; but, in the vast majority of cases, the side effects from the ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

A new study has found that a significant percentage of adults in the United States have at least one risk factor for severe respiratory syncytial virus (RSV), even as eligibility for the RSV ...

In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...

FDA officials are newly scrutinizing several approved therapies to treat RSV in babies despite the fact that these shots were shown to be safe in clinical trials ...

Food and Drug Administration officials have opened a safety review of two injectable drugs used to protect babies and ...

Over the course of a two-day meeting, vaccine advisers to the US Food and Drug Administration voted in favor of approval for RSV vaccines for adults over the age of 60. The vaccine candidates, made by ...

Research led by the Veterans Affairs Portland Health Care System in Portland, Oregon, found that a single dose of respiratory ...

HIQA has launched a public consultation on its draft health technology assessment of immunisation against the Respiratory ...

GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) ...

Doctors say colder weather brings an increase in respiratory infections, flu, RSV and other seasonal illnesses. A pediatric ...

Stay healthy this holiday season by getting vaccinated against COVID-19, flu, RSV, and other viruses. Consult a healthcare professional for guidance.